22P BCL2 Negative Breast Tumors but not Axillary Lymph Nodes Predict a Better Overall Survival in Patients Treated with Higher Doses of Epirubicin at a Median follow-up of 15.6 Years
Keyword(s):
2001 ◽
Vol 93
(18)
◽
pp. 1420-1420
◽
2021 ◽
Keyword(s):
Keyword(s):
2004 ◽
Vol 10
(3)
◽
pp. 174-180
◽
Keyword(s):
Keyword(s):
2001 ◽
Vol 93
(2)
◽
pp. 112-120
◽
2008 ◽
Vol 34
(10)
◽
pp. 1173-1174
Keyword(s):
2010 ◽
Vol 1
(1)
◽
pp. 68-75
◽
2009 ◽
Vol 16
(12)
◽
pp. 3388-3395
◽